Liver Disease & ALD

A major healthcare goal of the Scottish Government is to reduce alcohol-related harm, in all its many manifestations. Much of the cost, morbidity and mortality of alcohol-related disease is driven by alcohol-related liver disease.

In 2017 SHAAP launched its report, ‘Alcohol-related Liver Disease: Guidance for Good Practice’ at the Royal College of Physicians of Edinburgh, with the support and participation of the Chief Medical Officer for Scotland, Dr Catherine Calderwood. The Guidance was drawn up by a multi-disciplinary group of healthcare specialists chaired by Professor John Dillon, University of Dundee and NHS Tayside.

The document makes recommendations for an alcohol-related liver disease care pathway for use by GPs, addiction services and acute general hospitals in relation to:

  1. Identification and early assessment of patients with alcohol-related liver disease and/or liver fibrosis
  2. Treatment of alcohol-related liver failure
  3. Follow-up; as well as
  4. Recommendations for research.

 

Dissemination of the guidance across Scotland

A copy of the Guidance was sent to every GP surgery in Spring 2018 and in Summer 2019 a survey of health boards was carried out. Report coming soon

 

Sharing good practice

If you have good practice in the area of treatment and care of patients with alcohol-related liver disease which you would like to share via this webpage, please  contact Felicity Garvie at: shaap@rcpe.ac.uk  

 

Sharing information

For a hard copy of the SHAAP Guidance, please contact Felicity as above.

Presentation by Dr Lesley Graham at the Launch.

Image
Image